Advanced Enzyme Technologies Limited Recommends Final Dividend for the Financial Year 2022-23; Declares an Interim Dividend for the Financial Year 2023-24, Payable on or Before June 11, 2023
May 13, 2023 at 03:53 am
Share
Advanced Enzyme Technologies Limited informed that the Board of Directors at its Meeting held on May 13, 2023. Recommended a Final Dividend @ 50% i.e. INR 1 per Equity Share on the face value of INR 2 each for the financial year 2022-23, subject to the approval of the Shareholders at the upcoming 34th Annual General Meeting of the Company ("AGM"). The Final Dividend, if approved/declared by the Shareholders at 34th AGM, will be paid on and from the second day from the date of AGM. Record date for the entitlement of Final Dividend, and date & timings for upcoming Annual General Meeting of the Company shall be intimated in due course of time.
Declared an Interim Dividend @ 200% i.e. INR 4 per Equity Share on the face value of INR 2 each for the financial year 2023-24. The Interim Dividend for Financial Year 2023- 23 will be paid to those shareholders whose names appear on the Register of Members of the Company or in the records of the Depositories as beneficial owners of the shares determined with reference to the Record Date of May 20, 2023, already announced for the said purpose by the Company vide its letter dated May 06, 2023. The aforesaid Interim Dividend will be paid to the Shareholders on or before June 11, 2023.
Advanced Enzyme Technologies Limited is an India-based company, engaged in manufacturing enzymes and probiotics. The Company is focused on the research and development, manufacturing, and marketing of approximately 400 products, which is developed from over 68 indigenous enzymes and probiotics. It provides solutions to various industries, such as human health care and nutrition, animal nutrition, baking, fruit, and vegetable processing, brewing, and malting, grain processing, protein modification, dairy processing, textile processing and others. It offers products and solutions for human nutrition, which include serratiopeptidase, fungal lactase, fungal lipase, and papain; animal nutrition, which include DigeGrain X, DigeGrain XL and DigeGrain M; food processing, including dairy and cheese processing and yeast processing, and non-food processing, including textiles processing, leather, and biofuels. Its oils and fats processing include oil extraction, oil refining, and others.
Advanced Enzyme Technologies Limited Recommends Final Dividend for the Financial Year 2022-23; Declares an Interim Dividend for the Financial Year 2023-24, Payable on or Before June 11, 2023